A powerful antitumor cytotoxic T-lymphocyte response against the colorectal cancer biomarker carcinoembryonic antigen was observed in advanced colorectal cancer patients treated with AEXs plus GM-CSF [231]. The gene discussed is CSF2; the disease is colorectal cancer.